Also trades as: 200028.SZ (SHZ) · $vol 0M
000028.SZ SHZ
China National Accord Medicines Corporation Ltd.
1W: -1.2%
1M: -1.3%
3M: -0.5%
YTD: -25.0%
1Y: -23.1%
3Y: -45.2%
5Y: -28.5%
¥19.66 ($2.93)
+0.29 (+1.50%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$47.6B
-0.0% ▼
5Y CAGR: +7.2%
Total Liabilities
$26.8B
+0.8% ▲
5Y CAGR: +8.1%
Shareholders Equity
$17.7B
+1.5% ▲
5Y CAGR: +6.6%
Cash & Investments
$7.4B
+13.9% ▲
5Y CAGR: -3.6%
Total Debt
$4.4B
-68.1% ▼
5Y CAGR: +6.3%
Net Debt
-$3.0B
-141.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $6.0B | $5.1B | $6.0B | $6.5B | $7.4B |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $6.0B | $5.1B | $6.0B | $6.5B | $7.4B |
| Net Receivables | $15.8B | $17.7B | $16.2B | $20.2B | $21.8B |
| Inventory | $6.3B | $7.6B | $7.8B | $8.0B | $7.4B |
| Other Current Assets | $849M | $1.4B | $1.7B | $1.6B | $223M |
| Total Current Assets | $29.3B | $31.8B | $31.7B | $36.4B | $37.6B |
| Property, Plant & Equip. | $3.3B | $3.5B | $3.4B | $3.7B | $3.5B |
| Goodwill & Intangibles | $3.5B | $3.4B | $3.4B | $3.4B | $2.3B |
| Long-Term Investments | $3.1B | $3.4B | $2.9B | $3.1B | $0 |
| Other Non-Current Assets | $408M | $460M | $996M | $112M | $3.9B |
| Total Non-Current Assets | $10.3B | $10.9B | $10.9B | $11.2B | $10.0B |
| Total Assets | $39.6B | $42.8B | $42.6B | $47.6B | $47.6B |
| — Liabilities — | |||||
| Accounts Payable | $15.2B | $16.7B | $15.2B | $7.5B | $18.1B |
| Short-Term Debt | $1.6B | $2.8B | $2.2B | $12.3B | $3.0B |
| Deferred Revenue | $2.6B | $2.8B | $587M | $0 | $0 |
| Other Current Liabilities | $1.2B | $490M | $647M | $1.9B | $1.4B |
| Total Current Liabilities | $20.3B | $22.4B | $21.0B | $24.3B | $24.8B |
| Long-Term Debt | $32M | $72M | $18M | $0 | $0 |
| Other Non-Current Liab. | $818M | $759M | $562M | $803M | $443M |
| Total Non-Current Liabilities | $2.4B | $2.4B | $2.1B | $2.3B | $2.0B |
| Total Liabilities | $22.7B | $24.8B | $23.2B | $26.6B | $26.8B |
| — Equity — | |||||
| Common Stock | $428M | $428M | $428M | $557M | $557M |
| Retained Earnings | $8.9B | $9.9B | $11.1B | $12.3B | $12.6B |
| Accumulated OCI | $2.5B | $2.5B | $2.5B | $8M | $2.5B |
| Total Stockholders Equity | $13.9B | $14.9B | $16.1B | $17.4B | $17.7B |
| Total Liabilities & Equity | $39.6B | $42.8B | $42.6B | $47.6B | $47.6B |
| — Key Metrics — | |||||
| Total Debt | $3.7B | $4.2B | $3.5B | $13.8B | $4.4B |
| Net Debt | -$2.3B | -$900M | -$2.5B | $7.2B | -$3.0B |
| Total Investments | $3.1B | $3.4B | $2.9B | $3.1B | $0 |